Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 49

1.

Topological scoring of protein interaction networks.

Sardiu ME, Gilmore JM, Groppe BD, Dutta A, Florens L, Washburn MP.

Nat Commun. 2019 Mar 8;10(1):1118. doi: 10.1038/s41467-019-09123-y.

2.

FGF2 Antiproliferative Stimulation Induces Proteomic Dynamic Changes and High Expression of FOSB and JUNB in K-Ras-Driven Mouse Tumor Cells.

Vitorino FNL, Montoni F, Moreno JN, de Souza BF, Lopes MC, Cordeiro B, Fonseca CS, Gilmore JM, Sardiu MI, Reis MS, Florens LA, Washburn MP, Armelin HA, da Cunha JPC.

Proteomics. 2018 Sep;18(17):e1800203. doi: 10.1002/pmic.201800203. Epub 2018 Aug 14.

PMID:
30035358
3.

Comparative Effectiveness of Two Models of Depression Services Quality Improvement in Health and Community Sectors.

Sherbourne CD, Aoki W, Belin TR, Bromley E, Chung B, Dixon E, Gilmore JM, Johnson MD, Jones F, Koegel P, Khodyakov D, Landry CM, Lizaola E, Mtume N, Ngo VK, Ong MK, Perlman J, Pulido E, Sauer V, Tang L, Whittington Y, Vidaurri E, Williams P, Lucas-Wright A, Zhang L, Miranda J, Jones L, Wells K.

Psychiatr Serv. 2017 Dec 1;68(12):1315-1320. doi: 10.1176/appi.ps.201700170. Epub 2017 Nov 1.

4.

Different phosphoisoforms of RNA polymerase II engage the Rtt103 termination factor in a structurally analogous manner.

Nemec CM, Yang F, Gilmore JM, Hintermair C, Ho YH, Tseng SC, Heidemann M, Zhang Y, Florens L, Gasch AP, Eick D, Washburn MP, Varani G, Ansari AZ.

Proc Natl Acad Sci U S A. 2017 May 16;114(20):E3944-E3953. doi: 10.1073/pnas.1700128114. Epub 2017 May 2.

5.

Identification of Topological Network Modules in Perturbed Protein Interaction Networks.

Sardiu ME, Gilmore JM, Groppe B, Florens L, Washburn MP.

Sci Rep. 2017 Mar 8;7:43845. doi: 10.1038/srep43845.

6.

Chromatin remodeller Fun30Fft3 induces nucleosome disassembly to facilitate RNA polymerase II elongation.

Lee J, Choi ES, Seo HD, Kang K, Gilmore JM, Florens L, Washburn MP, Choe J, Workman JL, Lee D.

Nat Commun. 2017 Feb 20;8:14527. doi: 10.1038/ncomms14527.

7.

Therapeutic Targeting of MLL Degradation Pathways in MLL-Rearranged Leukemia.

Liang K, Volk AG, Haug JS, Marshall SA, Woodfin AR, Bartom ET, Gilmore JM, Florens L, Washburn MP, Sullivan KD, Espinosa JM, Cannova J, Zhang J, Smith ER, Crispino JD, Shilatifard A.

Cell. 2017 Jan 12;168(1-2):59-72.e13. doi: 10.1016/j.cell.2016.12.011. Epub 2017 Jan 5.

8.

SONAR Discovers RNA-Binding Proteins from Analysis of Large-Scale Protein-Protein Interactomes.

Brannan KW, Jin W, Huelga SC, Banks CA, Gilmore JM, Florens L, Washburn MP, Van Nostrand EL, Pratt GA, Schwinn MK, Daniels DL, Yeo GW.

Mol Cell. 2016 Oct 20;64(2):282-293. doi: 10.1016/j.molcel.2016.09.003. Epub 2016 Oct 6.

9.

Accurate de novo design of hyperstable constrained peptides.

Bhardwaj G, Mulligan VK, Bahl CD, Gilmore JM, Harvey PJ, Cheneval O, Buchko GW, Pulavarti SV, Kaas Q, Eletsky A, Huang PS, Johnsen WA, Greisen PJ, Rocklin GJ, Song Y, Linsky TW, Watkins A, Rettie SA, Xu X, Carter LP, Bonneau R, Olson JM, Coutsias E, Correnti CE, Szyperski T, Craik DJ, Baker D.

Nature. 2016 Oct 20;538(7625):329-335. doi: 10.1038/nature19791. Epub 2016 Sep 14.

10.

WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage.

Gilmore JM, Sardiu ME, Groppe BD, Thornton JL, Liu X, Dayebgadoh G, Banks CA, Slaughter BD, Unruh JR, Workman JL, Florens L, Washburn MP.

PLoS One. 2016 Jun 1;11(6):e0155492. doi: 10.1371/journal.pone.0155492. eCollection 2016.

11.

De novo design of protein homo-oligomers with modular hydrogen-bond network-mediated specificity.

Boyken SE, Chen Z, Groves B, Langan RA, Oberdorfer G, Ford A, Gilmore JM, Xu C, DiMaio F, Pereira JH, Sankaran B, Seelig G, Zwart PH, Baker D.

Science. 2016 May 6;352(6286):680-7. doi: 10.1126/science.aad8865. Erratum in: Science. 2016 May 20;352(6288). pii: aag1318. doi: 10.1126/science.aag1318.

12.
13.

Assembly of the Elongin A Ubiquitin Ligase Is Regulated by Genotoxic and Other Stresses.

Weems JC, Slaughter BD, Unruh JR, Hall SM, McLaird MB, Gilmore JM, Washburn MP, Florens L, Yasukawa T, Aso T, Conaway JW, Conaway RC.

J Biol Chem. 2015 Jun 12;290(24):15030-41. doi: 10.1074/jbc.M114.632794. Epub 2015 Apr 15.

14.

Characterization of human cyclin-dependent kinase 12 (CDK12) and CDK13 complexes in C-terminal domain phosphorylation, gene transcription, and RNA processing.

Liang K, Gao X, Gilmore JM, Florens L, Washburn MP, Smith E, Shilatifard A.

Mol Cell Biol. 2015 Mar;35(6):928-38. doi: 10.1128/MCB.01426-14. Epub 2015 Jan 5.

15.

Conserved abundance and topological features in chromatin-remodeling protein interaction networks.

Sardiu ME, Gilmore JM, Groppe BD, Herman D, Ramisetty SR, Cai Y, Jin J, Conaway RC, Conaway JW, Florens L, Washburn MP.

EMBO Rep. 2015 Jan;16(1):116-26. doi: 10.15252/embr.201439403. Epub 2014 Nov 26.

16.

Suberoylanilide hydroxamic acid (SAHA)-induced dynamics of a human histone deacetylase protein interaction network.

Sardiu ME, Smith KT, Groppe BD, Gilmore JM, Saraf A, Egidy R, Peak A, Seidel CW, Florens L, Workman JL, Washburn MP.

Mol Cell Proteomics. 2014 Nov;13(11):3114-25. doi: 10.1074/mcp.M113.037127. Epub 2014 Jul 29.

17.

SILAC surrogates: rescue of quantitative information for orphan analytes in spike-in SILAC experiments.

Gilmore JM, Milloy JA, Gerber SA.

Anal Chem. 2013 Nov 19;85(22):10812-9. doi: 10.1021/ac4021352. Epub 2013 Nov 7.

18.

The SOX2-interactome in brain cancer cells identifies the requirement of MSI2 and USP9X for the growth of brain tumor cells.

Cox JL, Wilder PJ, Gilmore JM, Wuebben EL, Washburn MP, Rizzino A.

PLoS One. 2013 May 7;8(5):e62857. doi: 10.1371/journal.pone.0062857. Print 2013.

19.

Determination of protein interactome of transcription factor Sox2 in embryonic stem cells engineered for inducible expression of four reprogramming factors.

Gao Z, Cox JL, Gilmore JM, Ormsbee BD, Mallanna SK, Washburn MP, Rizzino A.

J Biol Chem. 2012 Mar 30;287(14):11384-97. doi: 10.1074/jbc.M111.320143. Epub 2012 Feb 9.

20.

Characterization of a highly conserved histone related protein, Ydl156w, and its functional associations using quantitative proteomic analyses.

Gilmore JM, Sardiu ME, Venkatesh S, Stutzman B, Peak A, Seidel CW, Workman JL, Florens L, Washburn MP.

Mol Cell Proteomics. 2012 Apr;11(4):M111.011544. doi: 10.1074/mcp.M111.011544. Epub 2011 Dec 22.

21.

Increasing phosphoproteomic coverage through sequential digestion by complementary proteases.

Gilmore JM, Kettenbach AN, Gerber SA.

Anal Bioanal Chem. 2012 Jan;402(2):711-20. doi: 10.1007/s00216-011-5466-5. Epub 2011 Oct 15.

22.

Combinatorial depletion analysis to assemble the network architecture of the SAGA and ADA chromatin remodeling complexes.

Lee KK, Sardiu ME, Swanson SK, Gilmore JM, Torok M, Grant PA, Florens L, Workman JL, Washburn MP.

Mol Syst Biol. 2011 Jul 5;7:503. doi: 10.1038/msb.2011.40.

23.

A CTSA-sponsored program for clinical research coordination: networking, education, and mentoring.

Brandt DS, Bosch M, Bayless M, Sinkey CA, Bodeker K, Sprenger K, Johnson K, Gilmore JM.

Clin Transl Sci. 2011 Feb;4(1):42-7. doi: 10.1111/j.1752-8062.2011.00259.x.

24.

Advances in shotgun proteomics and the analysis of membrane proteomes.

Gilmore JM, Washburn MP.

J Proteomics. 2010 Oct 10;73(11):2078-91. doi: 10.1016/j.jprot.2010.08.005. Epub 2010 Aug 23. Review.

PMID:
20797458
25.

Proteomic analysis of Sox2-associated proteins during early stages of mouse embryonic stem cell differentiation identifies Sox21 as a novel regulator of stem cell fate.

Mallanna SK, Ormsbee BD, Iacovino M, Gilmore JM, Cox JL, Kyba M, Washburn MP, Rizzino A.

Stem Cells. 2010 Oct;28(10):1715-27. doi: 10.1002/stem.494.

26.

Determinants of affinity and activity of the anti-sigma factor AsiA.

Gilmore JM, Bieber Urbauer RJ, Minakhin L, Akoyev V, Zolkiewski M, Severinov K, Urbauer JL.

Biochemistry. 2010 Jul 27;49(29):6143-54. doi: 10.1021/bi1002635.

27.

Determining protein complex connectivity using a probabilistic deletion network derived from quantitative proteomics.

Sardiu ME, Gilmore JM, Carrozza MJ, Li B, Workman JL, Florens L, Washburn MP.

PLoS One. 2009 Oct 6;4(10):e7310. doi: 10.1371/journal.pone.0007310.

28.

Rtr1 is a CTD phosphatase that regulates RNA polymerase II during the transition from serine 5 to serine 2 phosphorylation.

Mosley AL, Pattenden SG, Carey M, Venkatesh S, Gilmore JM, Florens L, Workman JL, Washburn MP.

Mol Cell. 2009 Apr 24;34(2):168-78. doi: 10.1016/j.molcel.2009.02.025.

29.
30.

Subjective and objective measures of physical activity in relationship to bone mineral content during late childhood: the Iowa Bone Development Study.

Janz KF, Medema-Johnson HC, Letuchy EM, Burns TL, Gilmore JM, Torner JC, Willing M, Levy SM.

Br J Sports Med. 2008 Aug;42(8):658-63. doi: 10.1136/bjsm.2008.047779. Epub 2008 Jul 4.

PMID:
18603581
31.

A general system for studying protein-protein interactions in Gram-negative bacteria.

Pelletier DA, Hurst GB, Foote LJ, Lankford PK, McKeown CK, Lu TY, Schmoyer DD, Shah MB, Hervey WJ 4th, McDonald WH, Hooker BS, Cannon WR, Daly DS, Gilmore JM, Wiley HS, Auberry DL, Wang Y, Larimer FW, Kennel SJ, Doktycz MJ, Morrell-Falvey JL, Owens ET, Buchanan MV.

J Proteome Res. 2008 Aug;7(8):3319-28. doi: 10.1021/pr8001832. Epub 2008 Jul 1.

PMID:
18590317
32.

Research-practice partners assess their first joint project.

Wenzel SL, Ebener P, Hunter SB, Watkins KE, Gilmore JM.

Sci Pract Perspect. 2005 Dec;3(1):38-45.

33.

A Bayesian estimator of protein-protein association probabilities.

Gilmore JM, Auberry DL, Sharp JL, White AM, Anderson KK, Daly DS.

Bioinformatics. 2008 Jul 1;24(13):1554-5. doi: 10.1093/bioinformatics/btn238. Epub 2008 May 22.

PMID:
18499697
34.

Multidimensional separations-based shotgun proteomics.

Fournier ML, Gilmore JM, Martin-Brown SA, Washburn MP.

Chem Rev. 2007 Aug;107(8):3654-86. Epub 2007 Jul 25. Review. No abstract available.

PMID:
17649983
35.

Physical activity and femoral neck bone strength during childhood: the Iowa Bone Development Study.

Janz KF, Gilmore JM, Levy SM, Letuchy EM, Burns TL, Beck TJ.

Bone. 2007 Aug;41(2):216-22. Epub 2007 May 10.

36.

Deciphering the combinatorial histone code.

Gilmore JM, Washburn MP.

Nat Methods. 2007 Jun;4(6):480-1. No abstract available. Erratum in: Nat Methods. 2007 Aug;4(8):673.

PMID:
17538629
37.

Global marketing of cholesterol-lowering drugs as therapy.

Elimimian JU, Gilmore JM, Singletary TJ.

J Hosp Mark Public Relations. 2006;16(1-2):15-28.

PMID:
17194684
38.

Transcriptional genomics associates FOX transcription factors with human heart failure.

Hannenhalli S, Putt ME, Gilmore JM, Wang J, Parmacek MS, Epstein JA, Morrisey EE, Margulies KB, Cappola TP.

Circulation. 2006 Sep 19;114(12):1269-76. Epub 2006 Sep 4.

PMID:
16952980
39.

N-terminal protein modification through a biomimetic transamination reaction.

Gilmore JM, Scheck RA, Esser-Kahn AP, Joshi NS, Francis MB.

Angew Chem Int Ed Engl. 2006 Aug 11;45(32):5307-11. No abstract available. Erratum in: Angew Chem Int Ed Engl. 2008;47(41):7788.

PMID:
16847857
40.

Physical activity augments bone mineral accrual in young children: The Iowa Bone Development study.

Janz KF, Gilmore JM, Burns TL, Levy SM, Torner JC, Willing MC, Marshall TA.

J Pediatr. 2006 Jun;148(6):793-9.

PMID:
16769389
41.

Cloning, high yield overexpression, purification, and characterization of AlgH, a regulator of alginate biosynthesis in Pseudomonas aeruginosa.

Bieber Urbauer RJ, Gilmore JM, Rosasco SE, Hattle JM, Cowley AB, Urbauer JL.

Protein Expr Purif. 2005 Sep;43(1):57-64. Epub 2005 Mar 17.

PMID:
16084397
42.

Detection of cardiac allograft rejection and response to immunosuppressive therapy with peripheral blood gene expression.

Horwitz PA, Tsai EJ, Putt ME, Gilmore JM, Lepore JJ, Parmacek MS, Kao AC, Desai SS, Goldberg LR, Brozena SC, Jessup ML, Epstein JA, Cappola TP.

Circulation. 2004 Dec 21;110(25):3815-21. Epub 2004 Dec 6.

PMID:
15583081
43.

Adherence to the AICR cancer prevention recommendations and subsequent morbidity and mortality in the Iowa Women's Health Study cohort.

Cerhan JR, Potter JD, Gilmore JM, Janney CA, Kushi LH, Lazovich D, Anderson KE, Sellers TA, Folsom AR.

Cancer Epidemiol Biomarkers Prev. 2004 Jul;13(7):1114-20.

44.

Everyday activity predicts bone geometry in children: the iowa bone development study.

Janz KF, Burns TL, Levy SM, Torner JC, Willing MC, Beck TJ, Gilmore JM, Marshall TA.

Med Sci Sports Exerc. 2004 Jul;36(7):1124-31.

PMID:
15235315
45.

Discovery of novel heteroaryl-substituted chalcones as inhibitors of TNF-alpha-induced VCAM-1 expression.

Meng CQ, Zheng XS, Ni L, Ye Z, Simpson JE, Worsencroft KJ, Hotema MR, Weingarten MD, Skudlarek JW, Gilmore JM, Hoong LK, Hill RR, Marino EM, Suen KL, Kunsch C, Wasserman MA, Sikorski JA.

Bioorg Med Chem Lett. 2004 Mar 22;14(6):1513-7.

PMID:
15006393
46.

Characterization of the interactions between the bacteriophage T4 AsiA protein and RNA polymerase.

Simeonov MF, Bieber Urbauer RJ, Gilmore JM, Adelman K, Brody EN, Niedziela-Majka A, Minakhin L, Heyduk T, Urbauer JL.

Biochemistry. 2003 Jul 1;42(25):7717-26.

PMID:
12820881
47.

Solution structure and stability of the anti-sigma factor AsiA: implications for novel functions.

Urbauer JL, Simeonov MF, Urbauer RJ, Adelman K, Gilmore JM, Brody EN.

Proc Natl Acad Sci U S A. 2002 Feb 19;99(4):1831-5. Epub 2002 Feb 5.

48.

Conserved regions 4.1 and 4.2 of sigma(70) constitute the recognition sites for the anti-sigma factor AsiA, and AsiA is a dimer free in solution.

Urbauer JL, Adelman K, Urbauer RJ, Simeonov MF, Gilmore JM, Zolkiewski M, Brody EN.

J Biol Chem. 2001 Nov 2;276(44):41128-32. Epub 2001 Aug 22.

49.

Systems emphasizing cost containment in the surgical suite.

Gilmore JM.

Hosp Mater Manage Q. 1980 Feb;1(3):63-7. No abstract available.

PMID:
10245174

Supplemental Content

Loading ...
Support Center